• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

循环 microRNAs 对静脉血栓栓塞症诊断的预测价值:系统评价和诊断荟萃分析。

The predictive value of circulating microRNAs for venous thromboembolism diagnosis: A systematic review and diagnostic meta-analysis.

机构信息

Department of Pharmacy, Peking University First Hospital, No. 6, Dahongluochang Street, Xicheng District, Beijing 100034, China.

Department of Cardiology, Peking University First Hospital, No. 8, Xi Shi Ku Da Jie Street, Xicheng District, Beijing 100034, China.

出版信息

Thromb Res. 2019 Sep;181:127-134. doi: 10.1016/j.thromres.2019.07.024. Epub 2019 Jul 26.

DOI:10.1016/j.thromres.2019.07.024
PMID:31401416
Abstract

OBJECTIVE

Venous thromboembolism (VTE) is a common cardiovascular disease, in which pulmonary embolism (PE) is potentially life-threatening. Accurate biological markers for the early diagnosis of VTE are needed. The purpose of this study was to analyze and validate the predictive value of microRNAs for the diagnosis of VTE.

METHODS

A comprehensive literature review was conducted using the PubMed, Embase, and Cochrane Library databases and is current through Sep 27, 2018. The diagnostic value of microRNAs for VTE was analyzed by creating a summary receiver operating characteristic curve (SROC) and calculating the area under the curve (AUC).

RESULTS

Our analysis included 12 articles assessing a total of 1057 individuals. The most frequently researched microRNA was miR-134, and the pooled results of the predictive ability of this miRNA with 95% confidence intervals (CIs) showed an average sensitivity of 0.82 (0.69-0.91) and an average specificity of 0.83 (0.68-0.92). The average AUC for the SROC curves was 0.89 (0.86-0.92). For other microRNAs, AUC values >0.8 were considered as potential diagnostic indices. These microRNAs included miR-1233, miR-134, miR-145, miR-483-3p, miR-582, miR-532, and miR-195.

CONCLUSIONS

MicroRNAs may act as novel diagnostic biomarkers for VTE, and miR-1233, miR-134, miR-145, miR-483-3p, miR-582, miR-532, and miR-195 are prime candidates. Of these, research on miR-134 is the most extensive and reliable.

摘要

目的

静脉血栓栓塞症(VTE)是一种常见的心血管疾病,其中肺栓塞(PE)可能危及生命。需要准确的生物标志物来早期诊断 VTE。本研究旨在分析和验证 microRNAs 对 VTE 的诊断价值。

方法

通过使用 PubMed、Embase 和 Cochrane Library 数据库进行全面的文献回顾,检索截至 2018 年 9 月 27 日的文献。通过创建汇总受试者工作特征曲线(SROC)并计算曲线下面积(AUC)来分析 microRNAs 对 VTE 的诊断价值。

结果

我们的分析包括 12 篇评估总共 1057 个人的文章。研究最多的 microRNA 是 miR-134,该 miRNA 的预测能力的汇总结果(95%置信区间 [CI])显示平均敏感度为 0.82(0.69-0.91),平均特异性为 0.83(0.68-0.92)。SROC 曲线的平均 AUC 为 0.89(0.86-0.92)。对于其他 microRNAs,AUC 值>0.8 被认为是潜在的诊断指标。这些 microRNAs 包括 miR-1233、miR-134、miR-145、miR-483-3p、miR-582、miR-532 和 miR-195。

结论

microRNAs 可能作为 VTE 的新型诊断生物标志物,miR-1233、miR-134、miR-145、miR-483-3p、miR-582、miR-532 和 miR-195 是潜在的候选物。其中,miR-134 的研究最为广泛和可靠。

相似文献

1
The predictive value of circulating microRNAs for venous thromboembolism diagnosis: A systematic review and diagnostic meta-analysis.循环 microRNAs 对静脉血栓栓塞症诊断的预测价值:系统评价和诊断荟萃分析。
Thromb Res. 2019 Sep;181:127-134. doi: 10.1016/j.thromres.2019.07.024. Epub 2019 Jul 26.
2
Association of recurrent venous thromboembolism and circulating microRNAs.复发性静脉血栓栓塞与循环 microRNAs 的关联。
Clin Epigenetics. 2019 Feb 13;11(1):28. doi: 10.1186/s13148-019-0627-z.
3
The role of soluble P selectin in the diagnosis of venous thromboembolism.可溶性 P 选择素在静脉血栓栓塞症诊断中的作用。
Thromb Res. 2014 Jan;133(1):17-24. doi: 10.1016/j.thromres.2013.08.014. Epub 2013 Aug 23.
4
Characteristics of platelet count and size and diagnostic accuracy of mean platelet volume in patients with venous thromboembolism. A systematic review and meta-analysis.血小板计数和大小的特征及平均血小板体积在静脉血栓栓塞症患者中的诊断准确性。系统评价和荟萃分析。
Platelets. 2019;30(2):139-147. doi: 10.1080/09537104.2017.1414175. Epub 2017 Dec 18.
5
Diagnostic significance of circulating miRNAs in systemic lupus erythematosus.循环 miRNA 在系统性红斑狼疮中的诊断意义。
PLoS One. 2019 Jun 4;14(6):e0217523. doi: 10.1371/journal.pone.0217523. eCollection 2019.
6
Plasma microRNAs as potential biomarkers in diagnosis of acute venous thromboembolism.血浆 microRNAs 作为急性静脉血栓栓塞症诊断的潜在生物标志物。
Clin Hemorheol Microcirc. 2023;84(4):435-448. doi: 10.3233/CH-231820.
7
Diagnostic accuracy of biomarker D-dimer in patients after stroke suspected from venous thromboembolism: A diagnostic meta-analysis.生物标志物D-二聚体在疑似静脉血栓栓塞性卒中患者中的诊断准确性:一项诊断性荟萃分析。
Clin Biochem. 2019 Jan;63:126-134. doi: 10.1016/j.clinbiochem.2018.09.011. Epub 2018 Sep 24.
8
Differential expression of plasma miRNAs in patients with unprovoked venous thromboembolism and healthy control individuals.不明原因静脉血栓栓塞症患者与健康对照个体血浆微小RNA的差异表达
Thromb Res. 2015 Sep;136(3):566-72. doi: 10.1016/j.thromres.2015.07.005. Epub 2015 Jul 15.
9
The Association of Neutrophil-Lymphocyte Ratio with Venous Thromboembolism: A Systematic Review and Meta-Analysis.中性粒细胞与淋巴细胞比值与静脉血栓栓塞症的相关性:系统评价和荟萃分析。
Clin Appl Thromb Hemost. 2022 Jan-Dec;28:10760296221130061. doi: 10.1177/10760296221130061.
10
Diagnostic significance of microRNAs in sepsis.microRNAs 在脓毒症中的诊断意义。
PLoS One. 2023 Feb 22;18(2):e0279726. doi: 10.1371/journal.pone.0279726. eCollection 2023.

引用本文的文献

1
Non-coding RNAs regulating endothelial progenitor cells for venous thrombosis: promising therapy and innovation.非编码 RNA 调控内皮祖细胞治疗静脉血栓形成:有前途的治疗方法和创新。
Stem Cell Res Ther. 2024 Jan 2;15(1):7. doi: 10.1186/s13287-023-03621-z.
2
Small-Extracellular-Vesicle-Derived miRNA Profile Identifies miR-483-3p and miR-326 as Regulators in the Pathogenesis of Antiphospholipid Syndrome (APS).小细胞外囊泡衍生 miRNA 谱鉴定 miR-483-3p 和 miR-326 作为抗磷脂综合征(APS)发病机制中的调节因子。
Int J Mol Sci. 2023 Jul 18;24(14):11607. doi: 10.3390/ijms241411607.
3
Post-transcriptional control of haemostatic genes: mechanisms and emerging therapeutic concepts in thrombo-inflammatory disorders.
止血基因的转录后调控:血栓炎症性疾病的机制和新的治疗概念。
Cardiovasc Res. 2023 Jul 6;119(8):1624-1640. doi: 10.1093/cvr/cvad046.
4
Circulating miR-320a-3p and miR-483-5p level associated with pharmacokinetic-pharmacodynamic profiles of rivaroxaban.循环 miR-320a-3p 和 miR-483-5p 水平与利伐沙班的药代动力学-药效学特征相关。
Hum Genomics. 2022 Dec 28;16(1):72. doi: 10.1186/s40246-022-00445-5.
5
Circulating MicroRNAs for Diagnosis of Acute Pulmonary Embolism: Still a Long Way to Go.循环 microRNAs 用于急性肺栓塞的诊断:任重而道远。
Biomed Res Int. 2022 Jan 10;2022:4180215. doi: 10.1155/2022/4180215. eCollection 2022.
6
Downregulation of microRNA-200c-3p alleviates the aggravation of venous thromboembolism by targeting serpin family C member 1.下调 microRNA-200c-3p 通过靶向丝氨酸蛋白酶家族 C 成员 1 减轻静脉血栓栓塞症的加重。
Bioengineered. 2021 Dec;12(2):11156-11168. doi: 10.1080/21655979.2021.2005982.
7
The Function of microRNAs in Pulmonary Embolism: Review and Research Outlook.微小RNA在肺栓塞中的作用:综述与研究展望
Front Pharmacol. 2021 Oct 19;12:743945. doi: 10.3389/fphar.2021.743945. eCollection 2021.
8
Predictive Value of Circulating microRNA-134 Levels for Early Diagnosis of Acute Pulmonary Embolism: Meta-analysis.循环 microRNA-134 水平对急性肺栓塞早期诊断的预测价值:Meta 分析。
J Cardiovasc Transl Res. 2021 Aug;14(4):744-753. doi: 10.1007/s12265-020-10087-4. Epub 2021 Jan 6.
9
Role of microRNAs in Hemophilia and Thrombosis in Humans.微小 RNA 在人类血友病和血栓形成中的作用。
Int J Mol Sci. 2020 May 20;21(10):3598. doi: 10.3390/ijms21103598.
10
Role of microRNAs in Venous Thromboembolism.miRNAs 在静脉血栓栓塞中的作用。
Int J Mol Sci. 2020 Apr 9;21(7):2602. doi: 10.3390/ijms21072602.